SCHEMBL19690443

SCHEMBL19690443

Nc1cc(N2Cc3ccc(F)cc3C2)ccc1[N+](=O)[O-]

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.58
MAPT P10636 6/20 0.58
SIRT6 Q8N6T7 4/20 0.58
RECQL P46063 1/20 0.54
TDP1 Q9NUW8 2/20 0.43
ATM Q13315 1/20 0.43
TSHR P16473 1/20 0.43
HTT P42858 1/20 0.42
RAB9A P51151 1/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
KDM4E B2RXH2 1/20 0.42
HTR6 P50406 1/20 0.41
ALDH1A1 P00352 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C19 P33261 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
EED O75530 1/20 0.39
POLB P06746 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19690301 0.91 LMNA (0.58) LMNAMAPTSIRT6RECQLTDP1
SCHEMBL19690292 0.91 LMNA (0.58) LMNAMAPTSIRT6RECQLTDP1
SCHEMBL19690293 0.84 LMNA (0.54) LMNAMAPTSIRT6RECQLTDP1
SCHEMBL19690428 0.78 RAB9A (0.46) LMNAMAPTSIRT6TDP1ATM
SCHEMBL77039 0.76 TDP1 (0.64) LMNAMAPTSIRT6RECQLTDP1
SCHEMBL19690352 0.76 MAPT (0.55) LMNAMAPTSIRT6RECQLHTT
SCHEMBL19690360 0.76 MAPT (0.55) LMNAMAPTSIRT6RECQLHTT
SCHEMBL30059159 0.74 LMNA (1.00) LMNAMAPTSIRT6RECQLMEN1
SCHEMBL25877527 0.74 LMNA (0.94) LMNAMAPTSIRT6RECQLTDP1
SCHEMBL3109069 0.74 LMNA (1.00) LMNAMAPTSIRT6RECQLMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11858900-B2 Fluorinated 2-amino-4-(substituted amino)phenyl carbamate derivatives OCUTERRA THERAPEUTICS, INC. (US) 2024-01-02 US disclosed
US-20210309612-A1 FLUORINATED 2-AMINO-4-(SUBSTITUTED AMINO)PHENYL CARBAMATE DERIVATIVES OCUTERRA THERAPEUTICS, INC. 2021-10-07 US disclosed
EP-3468947-A1 FLUORINATED 2-AMINO-4-(SUBSTITUTED AMINO)PHENYL CARBAMATE DERIVATIVES SciFluor Life Sciences, Inc. (US) 2019-04-17 EP disclosed
WO-2017214539-A1 FLUORINATED 2-AMINO-4-(SUBSTITUTED AMINO)PHENYL CARBAMATE DERIVATIVES SCIFLUOR LIFE SCIENCES, INC. (US) 2017-12-14 WO disclosed
US-20170355679-A1 FLUORINATED 2-AMINO-4-(SUBSTITUTED AMINO)PHENYL CARBAMATE DERIVATIVES SCIFLUOR LIFE SCIENCES, INC. 2017-12-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170355679-A1 FLUORINATED 2-AMINO-4-(SUBSTITUTED AMINO)PHENYL CARBAMATE DERIVATIVES KCNQ2, KCNQ1, KCNQ3 LMNA 2343/4885MAPT 2123/4885SIRT6 1361/4885
US-11858900-B2 Fluorinated 2-amino-4-(substituted amino)phenyl carbamate derivatives KCNQ2, KCNQ1, KCNQ3 LMNA 2343/4885MAPT 2123/4885SIRT6 1361/4885
US-20210309612-A1 FLUORINATED 2-AMINO-4-(SUBSTITUTED AMINO)PHENYL CARBAMATE DERIVATIVES KCNQ2, KCNQ1, KCNQ3 LMNA 2343/4885MAPT 2123/4885SIRT6 1361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.